Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

HKI4MAG-99K

Millipore

MILLIPLEX® Human Kidney Injury Magnetic Bead Panel 4 - Toxicity Multiplex Assay

The analytes available for this multiplex kit are: EGF, FABP1, IP-10, KIM-1, Osteopontin (OPN), PTH and Renin.

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
12161503
eCl@ss :
32161000
Nomenclature NACRES :
NA.84

Niveau de qualité

Espèces réactives

human

Fabricant/nom de marque

Milliplex®

assay range

accuracy: 63-118%
intra-assay cv: <10
sensitivity: 0.01-0.71 ng/mL
(MinDC+2SD)

standard curve range: 0.01-5 ng/mL
(IP-10)

standard curve range: 0.012-12.5 ng/mL
(EGF)

standard curve range: 0.02-20 ng/mL
(PTH)

standard curve range: 0.15-150 ng/mL
(FABP1)

standard curve range: 0.17-1,200 ng/mL
(Osteopontin (OPN))

standard curve range: 0.20-200 ng/mL
(KIM-1)

standard curve range: 0.68-700 ng/mL
(Renin)

Technique(s)

multiplexing: suitable

Méthode de détection

fluorometric (Luminex xMAP)

Conditions d'expédition

wet ice

Description générale

Maintenance of physiological balance in the body is attributed in part to normal kidney function. Altered kidney function due to injury, drug toxicity or kidney failure may be life threatening. Toxicity is the leading cause of drug failure, so research is expanding in search of more sensitive, rapid methods to determine organ-specific damage as quickly as possible. Traditionally, blood urea nitrogen (BUN) and serum creatinine tests have been used to determine drug-induced damage to the kidney. These tests only detect kidney damage after it begins and do not allow for the elucidation of where in the kidney the damage has occurred. Specificity and earlier detection of kidney injury is vital, and this area of research is expanding in search of more sensitive, rapid methods for determining the specific area of damage in kidney.

The MILLIPLEX® portfolio provides valuable research assays to investigate multiple biomarkers of kidney injury in human serum and plasma samples using the Luminex® xMAP® instrument platform.

The MILLIPLEX® Human Kidney Injury Bead Panel 4 contains all the components necessary to measure the following seven biomarkers in any combination using Luminex® xMAP® technology: EGF, FABP1, IP-10, KIM-1, Osteopontin (OPN), PTH and Renin. The kit uses a 96-well format, contains a lyophilized standard cocktail, two quality controls and can measure up to 38 serum or plasma samples in duplicate.

Panel Type: Toxicity

Spécificité

Cross Reactivty
There was no or negligible cross-reactivity between the antibodies for an analyte and any of the other analytes within a panel.

Application

  • Analytes: EGF, FABP1, IP-10, KIM-1, Osteopontin (OPN), PTH, Renin
  • Recommended Sample type: serum and plasma
  • Recommended Sample dilution: 1:2 in kit Assay Buffer. Customers need to determine the optimal dilution factor for their samples. Our recommendations are on serum and plasma samples from normal subjects.
  • Assay Run Time: Overnight
  • Research Category: Toxicity

Caractéristiques et avantages

Design your multiplex kit by choosing available analytes within this panel.

Conditionnement

Everything you need in a single kit.

Stockage et stabilité

Recommended storage for kit components is 2 - 8°C.

Autres remarques

Please contact Technical Service for linearity of dilution.
Sensitivity: Please see kit protocol for individual assay sensitivities.

Informations légales

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

Organes cibles

Respiratory Tract

Code de la classe de stockage

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Annie Moisan et al.
Molecular therapy. Nucleic acids, 6, 89-105 (2017-03-23)
Antisense oligonucleotide (AON) therapeutics offer new avenues to pursue clinically relevant targets inaccessible with other technologies. Advances in improving AON affinity and stability by incorporation of high affinity nucleotides, such as locked nucleic acids (LNA), have sometimes been stifled by

Contenu apparenté

Multiplex kidney toxicity assays detect nephrotoxicity biomarkers in small samples, minimizing time and costs for toxicity screening.

Multiplex kidney toxicity assays detect nephrotoxicity biomarkers in small samples, minimizing time and costs for toxicity screening.

Multiplex kidney toxicity assays detect nephrotoxicity biomarkers in small samples, minimizing time and costs for toxicity screening.

Multiplex kidney toxicity assays detect nephrotoxicity biomarkers in small samples, minimizing time and costs for toxicity screening.

Afficher tout

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique